Laddar...
Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with (177)Lu-DOTATATE
BACKGROUND: Monitoring of pancreatic neuroendocrine tumors (PanNET) undergoing peptide receptor radionuclide therapy (PRRT) with (177)Lu-DOTATATE depends on changes in tumor size, which often occur late. Tumor growth rate (TGR) allows for quantitative assessment of the tumor kinetics expressed as %/...
Sparad:
| I publikationen: | Endocr Connect |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Bioscientifica Ltd
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111309/ https://ncbi.nlm.nih.gov/pubmed/33875614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-21-0027 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|